CLINICAL_TRIALS
trial_result
· 2021-10-04
Clinical Trial Update: TL011 in Severe, Active Rheumatoid Arthritis Patients [Phase 1]
Summary
Phase 1 trial update for TL011 in severe, active rheumatoid arthritis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Teva Pharmaceutical Industries, Ltd. | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED | Results posted: 2021-10-04